FDA Import Refusal 1FX-1726778-2/10002/1F — CNB INT
The FDA refused shipment 1FX-1726778-2/10002/1F from CNB INT (South Korea) on Sep 18, 2026. The refused product falls under Drugs and Biologics — MISCELLANEOUS PATENT MEDICINES, ETC.. Cited charge: 75
Refusal details
- Date
- Sep 18, 2026
- Country
- South Korea
- Product Category
- Drugs and Biologics
- Product Code
- 66VDK99 MISCELLANEOUS PATENT MEDICINES, ETC.
- Charges
- 75